Back to Peptides
PerformanceLow Risk

GHRP-2

Also known as: Growth Hormone Releasing Peptide 2, Pralmorelin, GHRP2

Half-life:
15–60 minutes

Administration Routes

subcutaneousintramuscular
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Synthetic hexapeptide that stimulates pulsatile growth hormone release from the anterior pituitary by acting on the ghrelin receptor (GHSR-1a). Commonly stacked with GHRH analogs such as CJC-1295 or Sermorelin to amplify GH output synergistically.

GHRP-2 is a synthetic growth hormone secretagogue that triggers natural GH release from the pituitary gland. It is commonly used alongside GHRH analogs to support muscle growth, fat loss, and recovery. For educational purposes only — consult a qualified healthcare provider.

Primary Research Areas

  • growth hormone release
  • muscle growth
  • fat loss
  • recovery
  • energy

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Consult a healthcare professional before use.

Regulatory Status

Research OnlyNot Evaluated by FDA

Approved for diagnostic GH stimulation testing in Japan (Kaken Pharma) but NOT FDA-approved. Not on FDA 503A Category 1 or Category 2 list. WADA prohibited. Research chemical in US.

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find GHRP-2